Rupert M Bauersachs

32PUBLICATIONS
130CO-AUTHORS
Exercise physiologyElectroanalytical chemistryPharmacogenomicsMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Feb 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.

Mario Enrico Canonico, Jessica Parr, E Sebastian Debus

|Nov 27, 2025
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.

Job Harenberg, Robert C Gosselin, Adam Cuker

|Oct 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Shea Hogan, Michael Szarek, E Sebastian Debus

|Aug 14, 2025
Triangulating data to define patient pathways, diagnostic and treatment patterns, and outcomes in cancer patients with deep vein thrombosis in Germany: a mixed-methods real-world data study.

Vanessa Colonna, Rupert Bauersachs, Roman Gerlach

|Jan 10, 2025
Dual pathway inhibition in patients with peripheral artery disease in Germany.

Joerg Herold, Nikolaos Dagkonakis, E Sebastian Debus

|Jan 08, 2025
Danaparoid-Consensus Recommendations on Its Clinical Use.

Rupert M Bauersachs, Edelgard Lindhoff-Last, Robert Klamroth

Pageof 6

Frequent Collaborators

10 joint publications

Marc P Bonaca

10 joint publications

Scott E Berkowitz

8 joint publications

Sonia S Anand

7 joint publications

Manesh R Patel